EIXSell
Edison International
Price (1y)
Recent regulatory events
- Going-concern disclosure (10-K)Annotate
Fair price check
5 different valuation methods each estimate what EIX should be worth, then we compare to today's price.
- P/E multiplesUndervaluedthinks it's a bargain — estimates $194.88, about 182% above today
- EV/EBITDAUndervaluedthinks it's a bargain — estimates $174.25, about 152% above today
- P/B multiplesUndervaluedthinks it's a bargain — estimates $103.71, about 50% above today
- Graham (defensive)Fairthinks it's fairly priced — estimates $77.89, about 13% above today
- Residual IncomeOvervaluedthinks it's expensive — estimates $53.29, about 23% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
| Method | Value |
|---|---|
| Graham (defensive) | $77.89 |
| P/E multiples(vs sub industry peers) | $194.88 |
| P/B multiples(vs sub industry peers) | $103.71 |
| EV/EBITDA(vs sub industry peers) | $174.25 |
| Residual Income | $53.29 |
| DCF (2-stage) | skipped |
Median of all applicable methods (current price $69.16). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Pillar breakdown
8 dimensions, each scored 0–100 against the universe
- QualityProfit margins & asset efficiency71Strong
- ValuePrice vs fundamentals84Strong
- GrowthRevenue & earnings trajectory79Strong
- MomentumRecent price strength72Strong
- HealthBalance sheet & solvency13Poor
- ProfitabilityROE, ROA, ROIC71Strong
- TechnicalTrend & volatility signals58Decent
- RiskVolatility & drawdown profile58Decent
Pillars not shown: Sentiment, ML (Phase 5+).
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $26.61B |
| Revenue (TTM) | $19.61B |
| Net income (TTM) | $3.78B |
| Operating cash flow (TTM) | $6.00B |
| CapEx (TTM) | $6.65B |
| Free cash flow (TTM)CFO − CapEx | $-643.00M |
| Total assets | $94.47B |
| Total liabilities | $75.59B |
| Stockholders' equity | $17.32B |
| Cash & equivalents | $168.00M |
| Shares outstanding | 384.79M |
| EPS (basic) | $1.38 |
| EPS (diluted) | $1.37 |
| P/E ratio (TTM) | 7.04 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-04-28
- Latest period end
- 2026-04-21
- Filing lag
- 18 days
- Missing metrics
- 6(gross_profit, cost_of_revenue, research_and_development, sga_expense, goodwill, intangibles_net)
Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.